bg
A

Alimera Sciences (ALIM)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Alimera Sciences (ALIM)

Alimera Sciences, Inc. is a commercial-stage global pharmaceutical company. The Company is engaged in developing and commercializing ILUVIEN for the treatment of diabetic macular edema (DME), a cause of blindness, and outside the United States for no... Read more

  • USD3.16
  • USD3.19
  • USD2.94
  • USD6.25
  • -12.30%
  • 59M
  • 75.00
  • 58.73k
  • 163M
  • 1.30
  • -45.30%
  • 19.30%

Unlock More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.